Bacterial strains used in this study are listed in Table 1. We selected sepA-positive strains from our collection of EAEC clinical isolates obtained from the Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT-TD) study, which investigated travelers’ diarrhea in UK and US military personnel deployed in Kenya, Djibouti, Afghanistan, and Honduras. ^{28 , 40} For an agg5A-positive, sepA-positive strain, we used D5613 (C267-15), a strain isolated from a pediatric case in Mozambique. ²⁹ HS is a commensal E. coli strain. ^{41 , 42} We defined EAEC as having both aggR (EAEC virulence gene regulator ^{43 – 46} ) and the genes for production of an AAF. The constructs used for this study are listed in Table 2.

Bacterial cultures were grown in a shaking incubator at 37°C with appropriate antibiotics, and diluted in Dulbecco’s Modified Eagle Medium (DMEM) with high glucose and L-glutamine (Genesee Scientific 25-501) to 10 ⁷ CFU/mL as estimated by optical density (OD). For those assays, 180 μL of the culture was added to a 96-well flat-bottom untreated plate (VWR 82050-760). DMEM was used as the control for each plate. After covering the plate with a lid, the plate was incubated at 37°C without shaking for the time indicated in the figure legend. After growth, the media on top of the biofilm was removed, and the biofilm was washed once with phosphate-buffered saline (PBS) (Fisher Scientific 70-011-044) before fixing with ethanol for 10 minutes. The dry biofilm plate was stained by immersing in a mixture of 3 mM crystal violet (Sigma Aldrich C0775), 5% ethanol, and water for 30 minutes then rinsed in tap water and dried. The bound crystal violet was eluted with 100 μL ethanol in each well, and the absorbance read at 590 nm. The control DMEM-only well values were subtracted from the absorbance values for all other wells.

To assess biofilm formation on glass disks, a single sterilized glass coverslip (Fisher 12-545-81P) was placed at the bottom of each well of a 24-well plate. Each well was then inoculated with 500 μL of 10 ⁷ CFU/mL bacteria in DMEM, and then otherwise treated identically to the 96-well plate biofilm method. After fixing and crystal violet staining, each disk was removed and glued to a glass slide with Cytoseal XYL (Thermo Scientific 8312-4) for imaging at 100× with oil immersion using an Olympus BX60F-3.

To test addition of components to the biofilm media, we supplemented the DMEM at the start of growth to 1 mg/ml DNase (Sigma Aldrich DN-25), 1 mg/ml chymotrypsin (Sigma Aldrich C4129), or 0.8 mM - 2.5 mM sodium metaperiodate (Fluka Analytical 71859). Another set of wells had the equivalent volume of vehicle control (PBS) added. For biofilm media with 2 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma Aldrich P7626) we made a stock of 100 mM in isopropanol and added the equivalent volume of isopropanol to a set of control wells.

To make DMEM with M9 levels of magnesium (10 mM Mg ²⁺), we grew biofilms in regular DMEM or DMEM with an extra 9.2 mM magnesium sulfate (Acros Organics 42390500).

Virulence gene deletion strains were constructed by lambda Red-mediated recombination with the pKD46 _spec plasmid. ^{47 , 48} In most cases, the entire gene was replaced with a kanamycin (kan), gentamicin, or chloramphenicol ( cat) resistance gene. Briefly, PCR primers, listed in Table 3, with approximately 50 nucleotides of homology to the wt gene were used to amplify the resistance gene. The PCR product was gel-purified following kit directions (Qiagen 28506) and electroporated into EAEC induced for expression of the lambda Red system (1 mM arabinose; Chem-Impex 01654), using a MicroPulser Electroporator set to 1.8 kilovolts with 200-ohm resistance (BioRad 1652100). ⁴⁹ After electroporation, the EAEC were incubated at 37°C for one hour to allow the recombination (based on homology to the primer regions) to proceed and for expression of the antibiotic resistance. Growth at 37°C also promotes loss of the pKD plasmid. ⁴⁸ Gene deletions were confirmed by PCR with specific screening primers listed in Table 3. We also confirmed, by plasmid sequencing, that the Δ sepA:: cat mutation was the only genetic change in pAA _K261-Δ sepA as compared to pAA _K261 and for pAA _P433-Δ sepA relative to pAA _P433, and that the sequence of revertant (pAA _K411-revertant) was correct.

To amplify PCR products larger than 4 kb, we used Platinum SuperFi II PCR Master mix (Invitrogen 12368010). For PCR products less than 4 kb, we used PfuUltra II Fusion HS Master mix (Agilent Technologies 600852). For confirmatory PCR from colonies, we used colony “boils” (one colony was added to 50 uL of water with a sterile toothpick and incubated for 12 min at 95°C), and the GoTaq Green Master mix kit (Fisher PRM7123).

To insert PCR products into pCR2.1TOPO (TOPO), we followed manufacturer guidelines (Invitrogen K280020). PCR products were purified using the QIAquick PCR & Gel Cleanup kit (Qiagen 28506). Plasmids were purified using the QIAprep Spin Miniprep kit (Qiagen 27106X4). To purify larger quantities of the pAA plasmid, we increased the yield of this large, low-copy vector by adding extra yeast extract to the Luria-Bertani (LB) broth (final concentration of 24 g/L yeast extract), as described by Wood et al. ⁵⁰ To move inserts into pACYC177, we digested the sepA inserts from the TOPO clones with BamHI (NEB R3136), then ligated the inserts into pACYC177. Primers were sourced from Integrated DNA Technologies and are listed in Table 3.

To allow the selection of colonies with sepA inserted into lacZ, we first added a kan resistance gene 200 bp downstream of sepA prior to amplification of the entire region for lambda Red-mediated replacement of the lacZ gene. We confirmed that addition of kan after sepA had no effect on biofilm staining in the wt strains (data not shown).

For the larger PCR construct, Δ lacZ:: sepA-kan, after amplification using K261 pAA-kan as a template, the construct was first inserted into TOPO per manufacturer instructions. The plasmid was then digested with NotI (NEB R3189) and BamHI (NEB R3136) and gel-purified to yield 500 ng of insert DNA and added to 100uL of electrocompetent cells for lambda Red recombination. The revertant strain (K411Δ cat:: sepA-kan) was identified by screening for loss of chloramphenicol resistance after recombineering with the Δ lacZ:: sepA-kan PCR ( Table 3). We confirmed the localization of SepA in the supernatant using Western blot analysis (data not shown).

We selected a spontaneous nalidixic acid resistant (Nal ^R) derivative of commensal E. coli HS ^{41 , 42} by growth on LB agar with 15 μg/mL nalidixic acid (Sigma Aldrich N4382). We moved the K261 pAA into HSNal ^R by centrifuging overnight cultures of both strains, resuspending the pellets in PBS, and mixing them (HSNal ^R and K261) at 1:1 v:v. After 5 minutes of incubation at room temperature, 75 μL of the cell mixture was spotted onto agar without any antibiotics and incubated for three hours. The mix was then inoculated onto MacConkey agar with 15 μg/mL nalidixic acid to select for HSNal ^R and 15 μg/mL tetracycline (Sigma Aldrich 37919) to select for pAA _K261 and grown overnight.

To get pAA _P433Δ sepA, pAA _K261Δ sepA, and pAA _P433 into HSNal ^R, the plasmids were purified as described above using extra yeast extract in the LB broth medium, then 1 μg of the plasmid was transformed into electrocompetent HSNal ^R cells. The transformed HSNal ^R was grown at 37°C overnight before plating on LB agar with 30 μg/mL chloramphenicol (Calbiochem 220551) to select for uptake of the pAAs with Δ sepA or 100 μg/mL ampicillin (Corning 61-238-RH) agar for pAA _P433.

In all cases, single colonies were screened by PCR to confirm the presence of aggR (pAA marker) and the absence of aaiC (EAEC chromosomal marker) to confirm uptake of the pAA plasmid.

A mutation in the active site of the SepA passenger domain ( sepA*) ( Table 2) was generated by splicing by overlap extension (SOE) PCR using primers SepAS211F and SepAS211R ( Table 3) to create the following changes: a799g & g800c in sepA which result in replacement of the serine at position 267 with an alanine. Next, the coding region for the passenger domains of K411 sepA and sepA* were amplified by PCR from TOPO:: sepA* and TOPO:: sepA to add BamHI and SalI cut sites, and ligated into the inducible vector pTrcHis2c (Invitrogen V36520) ( Table 2). The expression of SepA (or SepA _S267A*) from these plasmids would result in SepA with a hexahistidine (His ₆) tag added at the N terminus. We chose to use the His tag for purification purposes because both Scott-Tucker et al. and Charbonneau et al. showed that the serine protease activity of a SPATE passenger domain is retained even with an N-terminal hexahistidine-tag. ^{51 , 52} After optimizing SepA expression from TOP10 pTrcHis2c with 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) (Sigma Aldrich I6758), the bacterial cells were lysed with BugBuster Master mix (Novagen 71456). The protein was then purified with a HisTrap HP nickel column according to the manufacturer’s protocol (GE Healthcare 95056-204). The purity of fractions collected from the nickel column was evaluated on a 4-12% Bis-Tris gel (Invitrogen NP0324). The fractions with the 110 kDa His-SepA protein band were concentrated with an Amicon Ultra-15 centrifugal concentrator 50,000 MW (Fisher Scientific UFC905008). The same type of centrifugal concentrator was used for buffer exchange with PBS to remove the imidazole.

For harvesting K411 wt or K411Δ sepA supernatant, cultures were grown in DMEM high glucose, with L-glutamine (Genesee Scientific 25-501) at 37°C shaking for five hours prior to centrifugation. The supernatants were filtered with a 0.22 μm filter (Genesee Scientific 25-227) before concentrating 2,000-fold with an Amicon 50 kDa cutoff spin column (Fisher UFC905008). The concentrated supernatant was then added to the biofilm media at the start of incubation. For TOPO:: sepA or TOPO:: sepA* supernatants, the plasmid was grown in TOP10 cells (Invitrogen C404010) and harvested identically to the EAEC strains.

A peptide (K261 SepA _891-913) from the exposed regions of the passenger domain of SepA was selected to generate a rabbit anti-SepA polyclonal antibody. Pacific Immunology (Ramona, CA) made rabbit polyclonal antibodies by immunizing two rabbits with the peptide at day 0 with complete Freund’s adjuvant and then again on days 21, 42, and 70 with incomplete Freund’s adjuvant. On day 77, 25 ml of serum was collected and affinity purified. This animal protocol was approved by IACUC-designated member review on August 12, 2019 from Pacific Immunology (SOP-1).

Bacterial strains (listed in the figure legends) were grown at 37°C for four hours in DMEM with shaking for liquid culture conditions or without shaking for static biofilm cultures. The supernatants from those cultures were collected after centrifugation and precipitated with an equal volume of ethanol overnight at -20°C. Samples were denatured with NuPAGE ^® sample buffer (Invitrogen NP0008) and electrophoresed on a 4-12% Bis-Tris gel (Invitrogen NP0324). The proteins were transferred using an iBlot nitrocellulose transfer stack (Invitrogen IB301002) to nitrocellulose. The nitrocellulose blot was incubated for two hours at room temperature in PBS with 0.1% Tween (Fisher Scientific 424592500) with 5% nonfat dry skim milk (Lab Scientific M0841). After the blocking step, the nitrocellulose was incubated overnight at 4°C with the anti-SepA antibody, at a dilution of 1:4,000 or 1:7,000 (listed in the figure legend), in PBS-Tween-milk, then washed three times with PBS-Tween. Next, the blot was incubated with a 1:10,000 dilution of the secondary antibody (goat anti-rabbit HRP conjugate; Bio-Rad 1706515) in PBS-Tween at room temperature for two hours. The nitrocellulose blot was washed once with PBS-Tween and twice with PBS. The nitrocellulose blot was incubated with ECL Western Blotting Detection reagent according to the manufacturer’s instructions (GE Healthcare 45-002-401) and imaged with a GE Amersham 680 Blot Imager. Blot images were cropped but otherwise not manipulated.

To purify pAA DNA we used the Plasmid Midi Kit (Qiagen 12143) following the manufacturer’s published protocol. ⁵³ Sequencing of the DNA for pAA _P433, pAA _K261-Δ sepA, pAA _P433-Δ sepA, and pAA _K411-revertant was done by Plasmidsaurus (Eugene, OR). Additional DNA sequences were taken from published work. ^{28 , 29} A draft assembly was done with the Minimap2 plug-in ⁵⁴ with Geneious Prime 2023.0.4 ⁵⁵ then further refined by re-aligning all reads in Geneious Prime. Remaining ambiguous bases were resolved manually by a comparison of the sequence quality among the sequencing reads provided.

GraphPad Prism 10.0.3 ⁵⁶ was used to test significance of three or more biological replicates by unpaired t test for two groups or an ordinary one-way analysis of variance (ANOVA) with a correction for multiple comparisons. * P≤0.05; ** P≤0.01; *** P≤0.001; **** P≤0.0001.

In our EAEC isolate collection from the TrEAT-TD study, ⁴⁰ all of the typical EAEC strains positive by PCR for the sepA gene were also positive for either the aggA or agg4A AAF major subunit gene. We selected six of the recently isolated clinical strains that were positive for sepA for this study ( Table 1). The virulence gene profiles of these strains are found in Table 1. We deleted sepA in these strains by replacing sepA _49-4043 with a chloramphenicol resistance gene ( cat). We found that two EAEC strains exhibited increased biofilm staining after the deletion of sepA ( Figure 1). Based on that finding, we initially hypothesized that the proteolytic activity of SepA modulated biofilm formation in a subset of EAEC by either cleaving a protein on the surface of the EAEC or protein(s) within the biofilm. Although four of the strains tested were positive for agg4A, we also tested an aggA ⁺ strain, E131, and an agg5A ⁺ clinical strain, D5613 ²⁹ ( Table 1). Neither the aggA ⁺ nor the agg5A ⁺ Δ sepA strains showed a significant difference in biofilm staining ( Figure 1). These results suggested that SepA may only affect the biofilm of some agg4A-positive strains. We confirmed that no growth defects were present in a selection of four of the strains ( Figure 2).

In Figure 1, four isolates had a non-significant increase in biofilm staining for the Δ sepA mutant strain as compared to the wt parental strain. Because the overall biofilm levels were relatively high for all of the strains, we reasoned that we might be able to detect a significant difference between the wt and the Δ sepA derivative strains if we reduced the amount of time that the biofilms were allowed to develop. Therefore, we assessed when we could detect the elevated biofilm staining phenotype by testing shorter growth times for biofilm growth for K261 and K261Δ sepA ( Figure 3). We found that the increased biofilm staining by K261Δ sepA relative to K261 was apparent after five hours of biofilm growth and remained differentiated up to the typical 23-hour time point we used for longer biofilm assays ( Figure 3). We also observed a linear relationship between increased growth time and increased biofilm staining for each strain as predicted by a linear regression model, although the lines were not perfectly parallel ( Figure 3). The best separation in biofilm staining for K261 compared to K261Δ sepA was found for biofilms grown for less than nine hours ( Figure 3). Based on these results, we decreased the growth time of the biofilm to five to eight hours and re-tested the EAEC strain pairs for differences in biofilm staining. With the shorter biofilm growth time, we observed a statistically significant difference in staining for E131 and E161 as compared to the corresponding Δ sepA-derivative strains when we controlled for variability by normalization ( Figure 4). E131 has the aggA AAF gene ( Table 1), so these results demonstrate that the Δ sepA biofilm phenotype is not limited to strains with the agg4A gene. Strains P433Δ sepA ( agg4A) and D5613Δ sepA ( agg5A) did not show a statistically significant change in staining compared to the wt parental strain under these conditions ( Figure 4).

Since the original sepA deletion strategy left 96 nucleotides of the sepA coding region, we next made a deletion that left only the start and stop codons, and reversed the orientation of cat gene ( cat _rev) relative to sepA. K411Δ sepA::cat _rev exhibited increased biofilm staining compared to the wt parental strain ( Figure 5). This result indicates that the increased biofilm staining after deletion of sepA was not an artifact of the original mutation strategy.

We hypothesized that there might be an expression level difference or an amino acid difference within SepA among different EAEC strains that prevented a SepA-mediated reduction in biofilm staining in the wt strains. We found no nucleotide differences in the 185 bp upstream of sepA, a region that includes the binding region for the EAEC virulence regulator AggR, ^{57 , 58} for any of the strains in this study. This finding demonstrates that the sepA promoter is the same for all of the strains. Next, we compared the predicted amino acid sequences of SepA among the EAEC used in this study. There were several amino acid polymorphisms with respect to the predicted protein consensus derived from all strains combined: (K411: A51V), (K261: S905N), (E131: I183V, G194E, D1049N), (D5613: D1049N, H671N), (P433 & E161: A1277V). However, we observed no common amino acid change in SepA among the strains that showed a difference in biofilm staining when sepA was deleted compared to those that did not (P433 and D5613). The most interesting change identified was A1277V in E161 and P433. The A1277V change is in the predicted autotransporter beta domain, which is necessary for secretion of the proteolytic passenger domain into the supernatant. In other SPATEs, mutations in this domain can inhibit secretion of the SPATE. ^{51 , 59 – 62} Accordingly, we examined SepA secretion into the supernatant from a subset of EAEC in this study, shown below.

To investigate whether the increased biofilm staining observed when sepA is deleted from some EAEC but not others is related to SepA secretion levels, we performed Western blot analysis on EAEC culture supernatants. We were particularly interested in whether the amino acid substitution found only in E161 and P433 (A1277V) had an impact on secretion. We observed the same apparent SepA band in all the wt strains examined, and all the strains tested appeared to have approximately equal levels of SepA ( Figure 6). This finding was true for EAEC with (K411, K261, and E161) or without (P433) a difference in biofilm staining when sepA was deleted. We also examined the supernatants from statically-grown biofilms of K261 and P433 for SepA. Similar SepA bands were observed from the supernatant harvested from the biofilms of K161 and P433 ( Figure 6). There was no visible SepA band identified from the bacteria contained in the cell pellet from the biofilm-grown bacteria; therefore, we inferred that SepA was efficiently exported into the supernatant for both K261 and P433 ( Figure 6).

We also tested the impact of deletion of the EAEC virulence gene regulator, aggR (K261Δ aggR) on SepA secretion. AggR is known to positively regulate sepA expression via an AggR-binding site. ^{57 , 58} We found that some SepA was still secreted when aggR was deleted ( Figure 6). We also found that SepA was efficiently secreted by a laboratory strain carrying a high-copy plasmid containing the K261 sepA gene (which was inserted in the opposite orientation as the lac promoter), without AggR (TOPO:: sepA). This plasmid was later used as a part of our complementation work.

To visualize the biofilm after sepA was deleted, EAEC were grown on glass disks under the same conditions used for the 96-well biofilm assay ( Figure 7). We examined K261 (showed elevated biofilm staining as measured by OD when sepA was deleted) and P433 (no change in biofilm staining OD when sepA was deleted). We observed that the Δ sepA strain biofilm patterns were different than found in the wt strains. Both P433 and K261 appeared to be packed closer together than the respective Δ sepA strains ( Figure 7). However, this difference in biofilm appearance does not correlate to the quantitative amount of crystal violet staining, for reasons that are not clear.

We next sought to determine whether the differences in biofilm crystal violet staining for K261 and K261Δ sepA were due to differences in the bacterial numbers in the biofilm. We checked both the biofilm and biofilm supernatant for K261 and, for comparison, P433 as well as the corresponding Δ sepA strains. No differences in CFU were identified ( Figure 8). As the CFU from biofilms for K261, P433, and the Δ sepA derivative strains did not deviate, the staining differences were not due to reductions in bacterial numbers.

To identify the genes that might be responsible for the increased biofilm staining for K261Δ sepA, but not for P433Δ sepA, we transferred the pAAs from those strains into the commensal E. coli HSNal ^R which does not have the capacity to make biofilm. We successfully transferred pAA _K261 into HSNal ^R . We found that the K261 pAA did not confer biofilm formation on HSNal ^R ( Figure 9). That result is similar to those of Alves et al. who reported that the wt pAA plasmid from EAEC strain 042 does not confer the capacity to form biofilm to an E. coli K12 strain. ⁶³ In contrast, HSNal ^RpAA _K261Δ sepA demonstrated significantly increased biofilm staining ( Figure 9). This latter result indicated that the target of SepA is likely on the K261 pAA. We also put pAA _p433 and pAA _P433Δ sepA (does not confer elevated biofilm to P433) into HSNal ^R. Biofilm staining was not increased in HSNal ^R with either pAA _P433 or pAA _P433Δ sepA ( Figure 9). We also found that sepA alone or Δ sepA:: cat alone did not confer the capacity to form a biofilm on HSNal ^R (data not shown). Therefore, we concluded that the Δ sepA:: cat mutation alone is not sufficient to cause the increased biofilm staining of HSNal ^R that had pAA _K261Δ sepA.

Because it is likely that the target of SepA is encoded on the K261 pAA, and we predicted that deleting the gene for a target of SepA would result in a significant change in biofilm staining, we searched for genetic differences in the pAA _P433 as compared to pAA _K261. From that search, we found that the pAA _P433 lacks most of the tra (plasmid transfer) genes. Therefore, we deleted the tra region from pAA _K261 (pAAΔ psiB-orf8) and assessed biofilm formation ( Figure 10). Because we found no significant difference in biofilm staining between K261 and K261pAAΔ psiB-orf8, we concluded that the target for SepA was not encoded within the deleted region. Other gene deletions made in pAA _K411, Δ umuC- yccA, Δ finO, Δ parB similarly had no impact on biofilm staining (data not shown). We also searched for genes (excluding transposes) on the pAA for predicted amino acid differences found only in P433 and D5613. Excluding the previously deleted genes and mobile genetic elements, we identified lpxM (Lipid A biosynthesis myristoyltransferase) ⁶⁴ for which there were predicted amino acid differences between K261 and P433. However, because we found no impact of lpxM deletion on biofilm staining of K261 ( Figure 10B), we concluded that LpxM is not the target of SepA.

Next, because deletion of the gene for dispersin ( aap) increases biofilm staining for EAEC strain 042, ^{65 , 66} we tested a strain with a deletion of both aatA (encodes the dispersin transporter) and sepA. The positively-charged Aap protein is thought to help the AAF extend from the surface of the bacteria. ^{65 , 66} In Figure 7 we noted that Δ sepA bacteria in the biofilm were less compactly spaced than the wt, so we predicted that preventing export of dispersin would have the opposite effect. However, we found that biofilm formation for K261Δ sepAΔ aatA was increased, a result that suggests that dispersin is not a target for SepA ( Figure 10C). Next, we deleted agg4A, the gene that encodes the AAF major pilin subunit in the wt and Δ sepA background of K261 ( Figure 10C). We measured a significant reduction in biofilm staining for both strains, as would be predicted for loss of the AAF. ³⁵ Because biofilm formation by the K261Δ agg4AΔ sepA double deletion strain was indistinguishable from K261Δ agg4A, we cannot determine whether SepA has an impact on the AAF by this method. However, because the predicted amino acid sequence of Agg4A from K261 and P433 are identical, we hypothesized that Agg4A is not the target of SepA for K261. We next moved on to other strategies to identify how SepA affects biofilm staining in some of our strains.

We conducted several additional experiments to investigate potential mechanisms by which biofilm staining was increased after deletion of sepA. Because Arenas et al. showed that deletion of a SPATE in Neisseria led to increased biofilm via a surface charge change and eDNA (extracellular DNA) production, ⁶⁷ we asked if a surface charge difference could be observed in the EAEC strains that showed differential biofilm formation. In contrast to Arenas et al. we found that differences in cytochrome c binding (a proxy for surface charge) did not correlate with biofilm staining levels ( Figure 11). For example, K261Δ sepA had decreased cytochrome c binding compared to K261, but K411 and K411Δ sepA had no significant difference in cytochrome c binding ( Figure 11). For our next set of experiments, we attempted to manipulate the biofilm by addition of various compounds to the medium, Figure 12. ( A) To pursue the hypothesis that there might be increased eDNA present in the biofilm of strains with elevated biofilm staining, we tested the impact of DNase I on biofilm formation. We could detect no impact on biofilm staining when biofilms were grown with 1 mg/ml DNase I ( Figure 12A). ( B) Next, we asked whether treatment of the biofilm with an exogenous serine protease, chymotrypsin, would alter biofilm formation. We used a serine protease because SepA is a serine protease and we reasoned that it was possible that a broad-spectrum serine protease might be able to act similarly to SepA. However, no impact on the biofilm staining was observed in the strains that were treated with chymotrypsin ( Figure 12B). ( C) We tested the effects of sodium metaperiodate, a carbohydrate cleaving agent. Sodium metaperiodate had no impact on biofilm staining ( Figure 12C). ( D) Because SepA is a serine protease, we added phenylmethylsulfonyl fluoride (PMSF), a protease inhibitor, to the biofilm. We did not observe an impact on biofilm staining when 2mM PMSF was added to the biofilm compared to the vehicle control (isopropanol) ( Figure 12D). This may be because PMSF is neutralized by other biofilm components over four hours, because the protease activity of SepA is not responsible for the Δ sepA phenotype, or because PMSF does not inhibit SepA under the conditions tested. ( E) Because we observed increased biofilm staining (data not shown) when EAEC were grown in M9 medium (has higher levels of magnesium than DMEM) and because magnesium affects the expression of genes on the large plasmid in Shigella, ⁶⁴ we supplemented DMEM to magnesium levels (10 mM Mg ²⁺) equivalent to that in M9. However, as shown in Figure 12E, Mg ²⁺ supplementation did not change biofilm staining significantly. Nor did magnesium lower the increased biofilm staining of K261Δ sepA ( Figure 12E). In summary, we did not observe a difference in biofilm response between the wt and Δ sepA strains for any of the tested treatments.

We hypothesized that a SepA-secreting strain should reduce the biofilm staining of K261Δ sepA to K261 levels. We therefore inoculated a biofilm plate with a mixture of K261Δ sepA and P433 (SepA secreter) or P433Δ sepA as a control. We selected P433 as the SepA-secreting strain because P433 and P433Δ sepA showed identical staining. Co-culture of P433 with K261Δ sepA did not significantly lower biofilm staining as compared to the P433Δ sepA (SepA non-secretor) ( Figure 13). There are several possible explanations for this observation. One, SepA only acts quite close to the surface of the bacteria, or similarly, is trapped within the biofilm. Second, that SepA is rapidly inactivated in the biofilm media, or, lastly, that SepA is not responsible for the increased crystal violet staining observed in K261Δ sepA.

We next added SepA directly to the biofilm. The SepA passenger domain is abundantly secreted into the supernatant for both EAEC and lab E. coli strains ( Figure 6 and Ref. 39). We chose K411 as the donor for the supernatant because it contains only one SPATE, SepA. We observed a significant reduction in staining for the K261Δ sepA biofilm grown with K411 supernatant ( Figure 14A). These results suggested that exogenously added SepA could reduce biofilm staining. Although the K411Δ sepA supernatant also slightly reduced K261Δ sepA biofilm staining ( Figure 14A), the reduction was not statistically significant. It may be that there were other factors present in the concentrated supernatant from K411Δ sepA, including waste products, which may impact biofilm growth.

To eliminate the possible influence of other EAEC elements within the supernatants, we concentrated the supernatant fraction from laboratory E. coli TOP10 cells that carried TOPO:: sepA (wt SepA protein) or TOPO:: sepA* (catalytically inactive SepA). The concentrated supernatant fractions were then added to the growing biofilms as before. The presence of the supernatant from the TOPO:: sepA construct did not lead to a statistically significant reduction in biofilm staining ( Figure 14B), despite the abundant presence of SepA in supernatants from that construct as shown by Western blot ( Figure 6).

As the concentrated supernatant from the TOP10 cells with either TOPO:: sepA or TOPO:: sepA* did not reduce biofilm formation, but the concentrated supernatant from K411 did, we next asked whether purified SepA protein could function to reduce biofilm staining for K261Δ sepA. We expressed the His-tagged SepA passenger domain (His-SepA) as previously described for other SPATEs. ^{25 , 68 , 69} The catalytically inactive form of the SepA passenger domain (SepA*) was used as a control. The vehicle control (PBS), His-SepA, or His-SepA* was added to K261Δ sepA at the start of inoculation for the biofilm and again one hour before fixing the biofilm. As shown in Figure 15, no impact on biofilm staining was observed. This result, taken with mixed biofilm data, further suggested that the SepA protein may not be responsible for the difference between wt and Δ sepA biofilm staining. We were unable to measure the enzymatic activity of the His-SepA in this study due to the lack of a known substrate for the EAEC SepA. However, the utilized purification process has successfully been used in other studies to yield functional SPATEs. ^{51 , 52 , 68} Following the outcomes of these studies, we next utilized a genetic approach to test SepA.

To complement the Δ sepA mutation genetically, we transformed K261Δ sepA and K411Δ sepA with pACYC177:: sepA for complementation ( Figure 16). We confirmed SepA expression in the supernatant from pACYC177:: sepA ( Figure 17) and that there was no growth defect for Δ sepA strains with pACYC177:: sepA (data not shown). However, this construct failed to reduce biofilm staining of K261Δ sepA and K411Δ sepA as compared to the parental strains ( Figure 16).

Since the plasmid-based methods failed to complement the altered biofilm-staining phenotype in the Δ sepA strains, we next introduced sepA into the chromosome of K411Δ sepA, in the lacZ locus. However, we did not observe a reduction in biofilm staining of K411Δ sepAΔ lacZ:: sepA ( Figure 18). In our last attempt at complementation, we created a “revertant” strain in which sepA was inserted back onto the pAA in place of the deleted sepA. The revertant strain had equivalent biofilm staining as found for the Δ sepA strain ( Figure 18), a finding that demonstrated that the reason for the elevated biofilm staining in this strain is not due to the sepA deletion. Collectively, these data suggest that the lack of SepA did not cause the increase in the biofilm formation in the Δ sepA strains.